Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

JOURNAL ARTICLE published October 2020 in The Lancet Oncology

Authors: Aurélien Marabelle | Marwan Fakih | Juanita Lopez | Manisha Shah | Ronnie Shapira-Frommer | Kazuhiko Nakagawa | Hyun Cheol Chung | Hedy L Kindler | Jose A Lopez-Martin | Wilson H Miller | Antoine Italiano | Steven Kao | Sarina A Piha-Paul | Jean-Pierre Delord | Robert R McWilliams | David A Fabrizio | Deepti Aurora-Garg | Lei Xu | Fan Jin | Kevin Norwood | Yung-Jue Bang